The efficacy is not there, mate. Management know precisely what is happening at all times, but instead of informing the market, they give themselves bonuses.
The FDA has absolutely 0 influence on company announcements.
Management have not held back telling the market how amazing CF33 could be, but have failed miserably to prove this. It might pay to go back and look over what I said regarding the preclinical and clinical evidence for CF33. You'll notice it has been fairly accurate, particularly in comparison to anything published by the company.
IMU Price at posting:
4.1¢ Sentiment: Sell Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)